HB 4890 Michigan House · 2023-2024 Regular Session

Health: pharmaceuticals; insulin production program; establish. Amends sec. 9 of 1984 PA 270 (MCL 125.2009) & adds ch. 8F.

This bill creates a new state program to partner with a private company for manufacturing and distributing insulin within Michigan to address rising costs and improve access for residents with diabetes. The state will provide up to $50 million in grants to help a selected contractor build or renovate facilities, provided the company owns the property and prioritizes creating local jobs. The program specifically seeks a partner that can produce both long-acting and rapid-acting insulin and must secure approval from the federal government regarding foreign investment before proceeding.
Bill status in committee 1 of 4 stages cleared
Introduction
Jul 2023
Committee Review
Floor Vote
Governor
Introduced Jul 18, 2023 Last action May 22, 2024
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
6
Key actions
1
Committee
3
May 22, 2024
Committee
referred to second reading
lower
May 22, 2024
Lower · Passed
reported with recommendation with substitute (H-2)
lower
Jul 18, 2023
Committee
referred to Committee on Health Policy
lower
Jul 18, 2023
Introduced
introduced by Representative Curtis VanderWall
lower
1 primary · 6 co-sponsors

Sponsors